{"id":"https://openalex.org/W2015987706","doi":"https://doi.org/10.1517/13543784.11.10.1365","title":"The therapeutic potential of the cannabinoids in neuroprotection","display_name":"The therapeutic potential of the cannabinoids in neuroprotection","alternate_titles":[],"publication_year":2002,"publication_date":"2002-10-01","ids":{"openalex":"https://openalex.org/W2015987706","doi":"https://doi.org/10.1517/13543784.11.10.1365","mag":"2015987706","pmid":"https://pubmed.ncbi.nlm.nih.gov/12387700"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.11.10.1365","doi":"https://doi.org/10.1517/13543784.11.10.1365","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.11.10.1365","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2015987706"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017332970","display_name":"Robert I. Grundy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert I Grundy","raw_affiliation_strings":["Neurology CEDD, GlaxoSmithKline, New Frontiers Science Park (North), Coldharbour Road, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology CEDD, GlaxoSmithKline, New Frontiers Science Park (North), Coldharbour Road, Harlow, Essex, CM19 5AW, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017332970"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":null,"apc_paid":null,"fwci":0.7203,"has_fulltext":false,"cited_by_count":85,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.54678363,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"11","issue":"10","first_page":"1365","last_page":"1374"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cannabinoids","display_name":"cannabinoids","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.7089999914169312},{"id":"https://openalex.org/keywords/cerebral-ischemia","display_name":"cerebral ischemia","score":0.9010000228881836},{"id":"https://openalex.org/keywords/traumatic-brain-injury","display_name":"traumatic brain injury","score":1.0},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9800000190734863},{"id":"https://openalex.org/keywords/huntington-s-disease","display_name":"Huntington's disease","score":1.0},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.7310000061988831},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.9129999876022339},{"id":"https://openalex.org/keywords/neurotransmitter-modulation","display_name":"neurotransmitter modulation","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cannabinoid-therapeutics","display_name":"cannabinoid therapeutics","score":0.574999988079071},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.92997145652771},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.7017542123794556},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6155826449394226},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5941969156265259},{"id":"https://openalex.org/C2780871563","wikidata":"https://www.wikidata.org/wiki/Q422936","display_name":"Cannabinoid","level":3,"score":0.5389652252197266},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.5370911955833435},{"id":"https://openalex.org/C2777846614","wikidata":"https://www.wikidata.org/wiki/Q19904200","display_name":"Synthetic cannabinoids","level":4,"score":0.5347989797592163},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4886205792427063},{"id":"https://openalex.org/C148001335","wikidata":"https://www.wikidata.org/wiki/Q421237","display_name":"Cannabinoid receptor","level":4,"score":0.4768142104148865},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.41006606817245483},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20137885212898254},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.19815689325332642},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0878095030784607},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07668954133987427},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002186","descriptor_name":"Cannabinoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002186","descriptor_name":"Cannabinoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002186","descriptor_name":"Cannabinoids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011955","descriptor_name":"Receptors, Drug","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011955","descriptor_name":"Receptors, Drug","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D043882","descriptor_name":"Receptors, Cannabinoid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543784.11.10.1365","doi":"https://doi.org/10.1517/13543784.11.10.1365","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.11.10.1365","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:12387700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12387700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":91,"referenced_works":["https://openalex.org/W22231678","https://openalex.org/W111663151","https://openalex.org/W155992401","https://openalex.org/W165936316","https://openalex.org/W1489583524","https://openalex.org/W1506884824","https://openalex.org/W1597830591","https://openalex.org/W1670633125","https://openalex.org/W1685180105","https://openalex.org/W1803077191","https://openalex.org/W1812356957","https://openalex.org/W1836729582","https://openalex.org/W1893117746","https://openalex.org/W1910892416","https://openalex.org/W1931308193","https://openalex.org/W1946756321","https://openalex.org/W1968911801","https://openalex.org/W1970391423","https://openalex.org/W1971614669","https://openalex.org/W1972155857","https://openalex.org/W1973258967","https://openalex.org/W1973645562","https://openalex.org/W1974642601","https://openalex.org/W1979169556","https://openalex.org/W1982604009","https://openalex.org/W1982609058","https://openalex.org/W1987107701","https://openalex.org/W1989021659","https://openalex.org/W1989073099","https://openalex.org/W1998309270","https://openalex.org/W1998929064","https://openalex.org/W2001413877","https://openalex.org/W2002908129","https://openalex.org/W2003253817","https://openalex.org/W2010214078","https://openalex.org/W2015561606","https://openalex.org/W2016083532","https://openalex.org/W2018953051","https://openalex.org/W2020978550","https://openalex.org/W2024109107","https://openalex.org/W2025974539","https://openalex.org/W2026926066","https://openalex.org/W2029181309","https://openalex.org/W2029651427","https://openalex.org/W2032715817","https://openalex.org/W2040051923","https://openalex.org/W2045210813","https://openalex.org/W2045563360","https://openalex.org/W2047690461","https://openalex.org/W2050474627","https://openalex.org/W2056188558","https://openalex.org/W2058354156","https://openalex.org/W2064128689","https://openalex.org/W2066242246","https://openalex.org/W2073116630","https://openalex.org/W2075171154","https://openalex.org/W2075894678","https://openalex.org/W2077467150","https://openalex.org/W2079879584","https://openalex.org/W2080282837","https://openalex.org/W2080383179","https://openalex.org/W2081183340","https://openalex.org/W2090873558","https://openalex.org/W2092950865","https://openalex.org/W2094720192","https://openalex.org/W2094807919","https://openalex.org/W2098025305","https://openalex.org/W2098783607","https://openalex.org/W2111689088","https://openalex.org/W2113319670","https://openalex.org/W2114728052","https://openalex.org/W2114932065","https://openalex.org/W2116169298","https://openalex.org/W2119898593","https://openalex.org/W2121127152","https://openalex.org/W2131204129","https://openalex.org/W2131697810","https://openalex.org/W2133325086","https://openalex.org/W2133559511","https://openalex.org/W2136399145","https://openalex.org/W2137734852","https://openalex.org/W2139955764","https://openalex.org/W2159270077","https://openalex.org/W2163915075","https://openalex.org/W2169182197","https://openalex.org/W2171143812","https://openalex.org/W2171226965","https://openalex.org/W2171422018","https://openalex.org/W2171637070","https://openalex.org/W2272316754","https://openalex.org/W2324311973"],"related_works":["https://openalex.org/W1146102393","https://openalex.org/W1979169556","https://openalex.org/W2161039247","https://openalex.org/W4408266567","https://openalex.org/W4211058634","https://openalex.org/W4243981487","https://openalex.org/W2807482700","https://openalex.org/W1965833191","https://openalex.org/W3112201883","https://openalex.org/W4206501585"],"abstract_inverted_index":{"After":[0],"thousands":[1],"of":[2,4,18,24,54,62,66,97,117,138,141,147,161,178,186],"years":[3],"interest":[5],"the":[6,19,52,133,136,156,179],"last":[7],"few":[8],"decades":[9],"have":[10,44],"seen":[11],"a":[12,139],"huge":[13],"increase":[14],"in":[15,94,114,144],"our":[16],"knowledge":[17],"cannabinoids":[20,90],"and":[21,42,48,71,75,105,125,149,175],"their":[22,40,83],"mode":[23],"action.":[25],"Their":[26],"potential":[27,84,188],"as":[28,73,85,102,122],"medical":[29],"therapeutics":[30],"has":[31,78,131],"long":[32],"been":[33],"known.":[34],"However,":[35],"very":[36],"real":[37],"concerns":[38],"over":[39],"safety":[41],"efficacy":[43],"lead":[45],"to":[46,57,68,81,170],"caution":[47],"suspicion":[49],"when":[50],"applying":[51],"legislature":[53],"modern":[55],"medicine":[56],"these":[58],"compounds.":[59],"The":[60],"ability":[61],"this":[63,173,184],"diverse":[64],"family":[65],"compounds":[67,153,187],"modulate":[69],"neurotransmission":[70],"act":[72],"anti-inflammatory":[74],"antioxidative":[76],"agents":[77],"prompted":[79],"researchers":[80],"investigate":[82],"neuroprotective":[86,189],"agents.":[87,190],"Indeed,":[88],"various":[89,145],"rescue":[91],"dying":[92],"neurones":[93],"experimental":[95,115],"forms":[96],"acute":[98],"neuronal":[99,150],"injury,":[100],"such":[101,121],"cerebral":[103],"ischaemia":[104],"traumatic":[106],"brain":[107],"injury.":[108],"Cannabinoids":[109],"also":[110],"provide":[111],"symptomatic":[112],"relief":[113],"models":[116],"chronic":[118],"neurodegenerative":[119],"diseases,":[120],"multiple":[123],"sclerosis":[124],"Huntington's":[126],"disease.":[127],"This":[128],"preclinical":[129],"evidence":[130],"provided":[132],"impetus":[134],"for":[135],"launch":[137],"number":[140],"clinical":[142],"trials":[143],"conditions":[146],"neurodegeneration":[148],"injury":[151],"using":[152],"derived":[154],"from":[155],"cannabis":[157],"plant.":[158],"Our":[159],"understanding":[160],"cannabinoid":[162],"neurobiology,":[163],"however,":[164],"must":[165],"improve":[166],"if":[167],"we":[168],"are":[169],"effectively":[171],"exploit":[172],"system":[174],"take":[176],"advantage":[177],"numerous":[180],"characteristics":[181],"that":[182],"make":[183],"group":[185]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2015987706","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
